Cargando…
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed
The outcomes of COVID-19 in patients treated with biologic agents are a subject of intense investigation. Recent data indicated that patients under rituximab (RTX) may carry an increased risk of serious disease. We performed an electronic search in Medline and Scopus using the keywords rituximab and...
Autores principales: | Daoussis, Dimitrios, Leonidou, Lydia, Kalogeropoulou, Christina, Paliogianni, Fotini, Tzouvelekis, Argyrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373601/ https://www.ncbi.nlm.nih.gov/pubmed/34409510 http://dx.doi.org/10.1007/s00296-021-04969-2 |
Ejemplares similares
-
Varicella-zoster virus aseptic meningitis: an atypical presentation in an immunocompetent male patient
por: Platanaki, Christina, et al.
Publicado: (2021) -
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
por: Daoussis, Dimitrios, et al.
Publicado: (2010) -
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review
por: Rodriguez-Pla, Alicia, et al.
Publicado: (2021) -
Acid-fast bacteria as causative agents of skin and soft tissue
infections: case presentations and literature review
por: Spiliopoulou, Anastasia, et al.
Publicado: (2023) -
Caution needed in the UK
por: Lawton, Graham
Publicado: (2021)